Bloomberg BNA's Pharmaceutical Law & Industry Report helps you stay informed of regulatory and litigation developments affecting the pharmaceutical and biotech industries....
By Alex Ruoff
Dec. 15 — The FDA plans to digitize its inspection and testing processes to improve the use of its own data, the agency's recently named chief information officer said Dec. 15.
The Food and Drug Administration in 2016 will connect its testing laboratories and field offices to allow inspectors and researchers to communicate freely and make use of agency data, Todd Simpson, CIO of the FDA, said. The data will be used to oversee FDA projects and investments to streamline processes and procedures, according to Simpson.
The agency also plans to hire a chief data officer to oversee changes to how the agency uses the information it collects in testing food, drugs and medical devices, Simpson said.
“Our labs across the U.S. are all using Ethernet,” he said, referring to the cables that connect computers to a network. “What we want is interoperability among our labs.”
The changes at the FDA will include rolling out a choose-your-own-device policy that allows FDA inspectors and administrators to choose from a number of smartphones to work from, Simpson said, speaking at the Armed Forces Communications and Electronics Association Health IT Day in Bethesda, Md.
The FDA in October unveiled its IT Strategic Plan, a three-year plan for improving internal IT systems at the agency.
The FDA has been plagued by fragmented IT networks—information systems that aren't connected, Simpson said. This means the FDA can't easily look at its own data for insights into how to improve its workforce or processes, he said.
The agency, however, collects a great deal of data about drugs and medical devices, Simpson, said, which could be put to better use.
“We're a big data shop and data governance is obviously very important to us,” he said. “We believe it's key.”
To contact the reporter on this story: Alex Ruoff in Washington at firstname.lastname@example.org
To contact the editor responsible for this story: Patty Logan at email@example.com
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)